BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

432 related articles for article (PubMed ID: 21178069)

  • 21. Multiparametric MR Imaging with High-Resolution Dynamic Contrast-enhanced and Diffusion-weighted Imaging at 7 T Improves the Assessment of Breast Tumors: A Feasibility Study.
    Pinker K; Baltzer P; Bogner W; Leithner D; Trattnig S; Zaric O; Dubsky P; Bago-Horvath Z; Rudas M; Gruber S; Weber M; Helbich TH
    Radiology; 2015 Aug; 276(2):360-70. PubMed ID: 25751227
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Limited role of DWI with apparent diffusion coefficient mapping in breast lesions presenting as non-mass enhancement on dynamic contrast-enhanced MRI.
    Avendano D; Marino MA; Leithner D; Thakur S; Bernard-Davila B; Martinez DF; Helbich TH; Morris EA; Jochelson MS; Baltzer PAT; Clauser P; Kapetas P; Pinker K
    Breast Cancer Res; 2019 Dec; 21(1):136. PubMed ID: 31801635
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Additional value of diffusion-weighted imaging to evaluate multifocal and multicentric breast cancer detected using pre-operative breast MRI.
    Song SE; Park EK; Cho KR; Seo BK; Woo OH; Jung SP; Cho SB
    Eur Radiol; 2017 Nov; 27(11):4819-4827. PubMed ID: 28593433
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MRI-only lesions: application of diffusion-weighted imaging obviates unnecessary MR-guided breast biopsies.
    Spick C; Pinker-Domenig K; Rudas M; Helbich TH; Baltzer PA
    Eur Radiol; 2014 Jun; 24(6):1204-10. PubMed ID: 24706105
    [TBL] [Abstract][Full Text] [Related]  

  • 25. How to manage type 2 curve dilemma in dynamic contrast-enhanced magnetic resonance imaging of the breast: diffusion-weighted imaging or early phase enhancement kinetics?
    Ulu Öztürk F; Tezcan Ş; Uslu N
    Acta Radiol; 2024 Apr; 65(4):341-349. PubMed ID: 38193154
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Retrospective analysis of the utility of multiparametric MRI for differentiating between benign and malignant breast lesions in women in China.
    Fan WX; Chen XF; Cheng FY; Cheng YB; Xu T; Zhu WB; Zhu XL; Li GJ; Li S
    Medicine (Baltimore); 2018 Jan; 97(4):e9666. PubMed ID: 29369183
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Improved diagnostic accuracy with multiparametric magnetic resonance imaging of the breast using dynamic contrast-enhanced magnetic resonance imaging, diffusion-weighted imaging, and 3-dimensional proton magnetic resonance spectroscopic imaging.
    Pinker K; Bogner W; Baltzer P; Gruber S; Bickel H; Brueck B; Trattnig S; Weber M; Dubsky P; Bago-Horvath Z; Bartsch R; Helbich TH
    Invest Radiol; 2014 Jun; 49(6):421-30. PubMed ID: 24566292
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differential diagnosis of mammographically and clinically occult breast lesions on diffusion-weighted MRI.
    Partridge SC; Demartini WB; Kurland BF; Eby PR; White SW; Lehman CD
    J Magn Reson Imaging; 2010 Mar; 31(3):562-70. PubMed ID: 20187198
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Diffusion tensor imaging for characterizing tumor microstructure and improving diagnostic performance on breast MRI: a prospective observational study.
    Luo J; Hippe DS; Rahbar H; Parsian S; Rendi MH; Partridge SC
    Breast Cancer Res; 2019 Sep; 21(1):102. PubMed ID: 31484577
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The actions of diffusion weighted imaging (DWI) and dynamic contrast enhanced MRI in differentiating breast tumors].
    Luo Y; Yu J; Chen D; Xu Z; Zeng H
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2013 Dec; 30(6):1219-23. PubMed ID: 24645600
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Subcategorization of Suspicious Breast Lesions (BI-RADS Category 4) According to MRI Criteria: Role of Dynamic Contrast-Enhanced and Diffusion-Weighted Imaging.
    Maltez de Almeida JR; Gomes AB; Barros TP; Fahel PE; de Seixas Rocha M
    AJR Am J Roentgenol; 2015 Jul; 205(1):222-31. PubMed ID: 26102403
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Improved performance in differentiating benign from malignant sinonasal tumors using diffusion-weighted combined with dynamic contrast-enhanced magnetic resonance imaging.
    Wang XY; Yan F; Hao H; Wu JX; Chen QH; Xian JF
    Chin Med J (Engl); 2015 Mar; 128(5):586-92. PubMed ID: 25698188
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Combining b2500 diffusion-weighted imaging with BI-RADS improves the specificity of breast MRI.
    Saccenti L; Mellon CM; Scholer M; Jolibois Z; Stemmer A; Weiland E; de Bazelaire C
    Diagn Interv Imaging; 2023 Sep; 104(9):410-418. PubMed ID: 37208291
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The diagnostic value of combining conventional, diffusion-weighted imaging and dynamic contrast-enhanced MRI for salivary gland tumors.
    Zheng N; Li R; Liu W; Shao S; Jiang S
    Br J Radiol; 2018 Sep; 91(1089):20170707. PubMed ID: 29902075
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diffusion-weighted imaging or dynamic contrast-enhanced curve: a retrospective analysis of contrast-enhanced magnetic resonance imaging-based differential diagnoses of benign and malignant breast lesions.
    Yang X; Dong M; Li S; Chai R; Zhang Z; Li N; Zhang L
    Eur Radiol; 2020 Sep; 30(9):4795-4805. PubMed ID: 32350660
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of the diagnostic performances of diffusion parameters in diffusion weighted imaging and diffusion tensor imaging of breast lesions.
    Cakir O; Arslan A; Inan N; Anık Y; Sarısoy T; Gumustas S; Akansel G
    Eur J Radiol; 2013 Dec; 82(12):e801-6. PubMed ID: 24099642
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Multiple parameters from ultrafast dynamic contrast-enhanced magnetic resonance imaging to discriminate between benign and malignant breast lesions: Comparison with apparent diffusion coefficient.
    Cao Y; Wang X; Shi J; Zeng X; Du L; Li Q; Nickel D; Zhou X; Zhang J
    Diagn Interv Imaging; 2023 Jun; 104(6):275-283. PubMed ID: 36739225
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Apparent diffusion coefficient values may help predict which MRI-detected high-risk breast lesions will upgrade at surgical excision.
    Cheeney S; Rahbar H; Dontchos BN; Javid SH; Rendi MH; Partridge SC
    J Magn Reson Imaging; 2017 Oct; 46(4):1028-1036. PubMed ID: 28181343
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diffusion-weighted imaging of breast masses: comparison of diagnostic performance using various apparent diffusion coefficient parameters.
    Hirano M; Satake H; Ishigaki S; Ikeda M; Kawai H; Naganawa S
    AJR Am J Roentgenol; 2012 Mar; 198(3):717-22. PubMed ID: 22358015
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Contribution of diffusion-weighted magnetic resonance imaging in the characterization of hepatocellular carcinomas and dysplastic nodules in cirrhotic liver.
    Xu PJ; Yan FH; Wang JH; Shan Y; Ji Y; Chen CZ
    J Comput Assist Tomogr; 2010 Jul; 34(4):506-12. PubMed ID: 20657216
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.